BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23175432)

  • 1. MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through nuclear factor kappa B pathways.
    Zhang L; Yang L; Liu X; Chen W; Chang L; Chen L; Loera S; Chu P; Huang WC; Liu YR; Yen Y
    Hepatology; 2013 May; 57(5):1919-30. PubMed ID: 23175432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling.
    Zhang Y; Wei W; Cheng N; Wang K; Li B; Jiang X; Sun S
    Hepatology; 2012 Nov; 56(5):1631-40. PubMed ID: 22610915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma.
    Ding J; Huang S; Wang Y; Tian Q; Zha R; Shi H; Wang Q; Ge C; Chen T; Zhao Y; Liang L; Li J; He X
    Hepatology; 2013 Aug; 58(2):654-66. PubMed ID: 23487264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.
    Su H; Yang JR; Xu T; Huang J; Xu L; Yuan Y; Zhuang SM
    Cancer Res; 2009 Feb; 69(3):1135-42. PubMed ID: 19155302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
    Zhao L; Zhang Y
    Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.
    Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J
    Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
    Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
    Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
    Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
    Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesis.
    Wu W; Yao DF; Qiu LW; Sai WL; Shen JJ; Yu HB; Wu XH; Li YM; Wang YL; Gu WJ
    Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):504-9. PubMed ID: 19822494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α.
    Bao C; Li Y; Huan L; Zhang Y; Zhao F; Wang Q; Liang L; Ding J; Liu L; Chen T; Li J; Yao M; Huang S; He X
    Sci Signal; 2015 Jul; 8(387):ra75. PubMed ID: 26221053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression.
    Zhang X; Liu S; Hu T; Liu S; He Y; Sun S
    Hepatology; 2009 Aug; 50(2):490-9. PubMed ID: 19472311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.
    Lang Q; Ling C
    Biochem Biophys Res Commun; 2012 Sep; 426(2):247-52. PubMed ID: 22940133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.
    Jia XQ; Cheng HQ; Qian X; Bian CX; Shi ZM; Zhang JP; Jiang BH; Feng ZQ
    Cell Biochem Biophys; 2012 Jan; 62(1):237-44. PubMed ID: 21847633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible connection between adhesion regulating molecule 1 overexpression and nuclear factor kappa B activity in hepatocarcinogenesis.
    Yang X; Miao X; Wen Y; Hu J; Dai W; Yin B
    Oncol Rep; 2012 Jul; 28(1):283-90. PubMed ID: 22576803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
    Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z
    Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.
    Zeng C; Wang R; Li D; Lin XJ; Wei QK; Yuan Y; Wang Q; Chen W; Zhuang SM
    Hepatology; 2010 Nov; 52(5):1702-12. PubMed ID: 21038412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis.
    Németh J; Stein I; Haag D; Riehl A; Longerich T; Horwitz E; Breuhahn K; Gebhardt C; Schirmacher P; Hahn M; Ben-Neriah Y; Pikarsky E; Angel P; Hess J
    Hepatology; 2009 Oct; 50(4):1251-62. PubMed ID: 19670424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma.
    Zhang Y; Guo X; Xiong L; Kong X; Xu Y; Liu C; Zou L; Li Z; Zhao J; Lin N
    FEBS Lett; 2012 Dec; 586(24):4362-70. PubMed ID: 23178713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.